Evado launches into Asia

By Staff Writers
Wednesday, 22 October, 2008

Melbourne company Evado has launched its clinical trial software into the growing south-east Asian market.

Evado is being distributed by local clinical research company SeerPharma.

Evado is a web-based mobile electronic data capture (EDC) system with two modules, one aimed at pre-clinical animal model trials and the other a clinical module for Phases I to IV.

It was developed in association with La Trobe University software researchers working at the university’s Microsoft Centre, along with Intel.

Evado CEO Jennie Anderson said the software was designed so that researchers can collect data on larger screens in a format similar to paper-based clinical research forms.

Related News

Novel antibiotic activates 'suicide' mechanism in superbug

Researchers have discovered a new class of antibiotic that selectively targets Neisseria...

Modifications in the placenta linked to psychiatric disorders

Schizophrenia, bipolar disorder and major depression disorder are the neuropsychiatric disorders...

ADHD may be linked with an increased risk of dementia

An adult brain affected by attention deficit hyperactivity disorder (ADHD) presents modifications...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd